Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females

被引:24
作者
Wang, Long [1 ]
Guo, Jinghui [1 ]
Lu, Jianping [2 ]
机构
[1] Shanghai Jiao Tong Univ, Dept Gastroenterol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China
[2] Shanghai Jiao Tong Univ, Hlth Examinat Ctr, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China
来源
ONCOTARGET | 2016年 / 7卷 / 24期
关键词
nonalcoholic fatty liver disease; body mass index; gender difference; risk factor compositions; nonalcoholic steatohepatitis; Pathology Section; AMERICAN ASSOCIATION; PRACTICE GUIDELINE; METABOLIC SYNDROME; STEATOHEPATITIS; PROGRESSION; MANAGEMENT; DIAGNOSIS; FIBROSIS; COLLEGE;
D O I
10.18632/oncotarget.9691
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Nonalcoholic fatty liver disease (NAFLD) is highly prevalent and correlated with obesity. To evaluate the role of body mass index (BMI) and gender difference in NAFLD, 8817 general adult subjects underwent physical examinations and were divided into four groups: underweight, normal, overweight and obese. The risk factor compositions for NAFLD were evaluated in each group by gender. The percentage of subjects with NAFLD increased sharply from 0.4% in the underweight group up to 81.9 % in the obese group. BMI stratification showed distinct risk factor compositions associated with NAFLD in males and females according to BMI and improved the performance of NAFLD prediction models in each group. Triglycerides (TG), alanine transaminase (ALT), aspartate transaminase (AST), and uric acid were steady risk factors for NAFLD in males. Total cholesterol (TC), TG, low-density lipoprotein cholesterol (LDL-C), ALT, and uric acid were steady risk factors for NAFLD in females. TG, ALT and uric acid were common risk factors in both genders with high performance for NAFLD discrimination. Our data provide gender-and BMI-specific risk factor compositions that will facilitate individualised treatment and benefit NAFLD control and prevention.
引用
收藏
页码:35632 / 35642
页数:11
相关论文
共 37 条
[1]   Metabolic syndrome and cardiovascular risk [J].
Alshehri, Abdullah M. .
JOURNAL OF FAMILY AND COMMUNITY MEDICINE, 2010, 17 (02) :73-78
[2]   Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis [J].
Anstee, Quentin M. ;
Targher, Giovanni ;
Day, Christopher P. .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (06) :330-344
[3]   The Fatty Liver Index: a simple and accurate predictor of hepatic steatosis in the general population [J].
Bedogni, Giorgio ;
Bellentani, Stefano ;
Miglioli, Lucia ;
Masutti, Flora ;
Passalacqua, Marilena ;
Castiglione, Anna ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2006, 6 (1)
[4]   A simple index of lipid overaccumulation is a good marker of liver steatosis [J].
Bedogni, Giorgio ;
Kahn, Henry S. ;
Bellentani, Stefano ;
Tiribelli, Claudio .
BMC GASTROENTEROLOGY, 2010, 10
[5]   Noninvasive evaluation of NAFLD [J].
Castera, Laurent ;
Vilgrain, Valerie ;
Angulo, Paul .
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (11) :666-675
[6]   Circulating MicroRNAs in Patients with Chronic Hepatitis C and Non-Alcoholic Fatty Liver Disease [J].
Cermelli, Silvia ;
Ruggieri, Anna ;
Marrero, Jorge A. ;
Ioannou, George N. ;
Beretta, Laura .
PLOS ONE, 2011, 6 (08)
[7]   The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
HEPATOLOGY, 2012, 55 (06) :2005-2023
[8]   The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology [J].
Chalasani, Naga ;
Younossi, Zobair ;
Lavine, Joel E. ;
Diehl, Anna Mae ;
Brunt, Elizabeth M. ;
Cusi, Kenneth ;
Charlton, Michael ;
Sanyal, Arun J. .
GASTROENTEROLOGY, 2012, 142 (07) :1592-1609
[9]   Lipoprotein Metabolism, Dyslipidemia, and Nonalcoholic Fatty Liver Disease [J].
Cohen, David E. ;
Fisher, Edward A. .
SEMINARS IN LIVER DISEASE, 2013, 33 (04) :380-388
[10]   ROLE OF THE LIVER IN THE DEGRADATION OF LIPOPROTEINS [J].
COOPER, AD .
GASTROENTEROLOGY, 1985, 88 (01) :192-205